View Future GrowthKromek Group 過去の業績過去 基準チェック /46Kromek Groupは、平均年間48.6%の収益成長を遂げていますが、 Semiconductor業界の収益は、年間 成長しています。収益は、平均年間5.3% 23%収益成長率で 成長しています。 Kromek Groupの自己資本利益率は22%であり、純利益率は33%です。主要情報48.60%収益成長率53.58%EPS成長率Semiconductor 業界の成長30.55%収益成長率23.04%株主資本利益率21.98%ネット・マージン33.04%前回の決算情報31 Oct 2025最近の業績更新お知らせ • Dec 16Kromek Group plc to Report First Half, 2026 Results on Jan 20, 2026Kromek Group plc announced that they will report first half, 2026 results on Jan 20, 2026Reported Earnings • Oct 28Full year 2024 earnings released: UK£0.006 loss per share (vs UK£0.014 loss in FY 2023)Full year 2024 results: UK£0.006 loss per share (improved from UK£0.014 loss in FY 2023). Revenue: UK£19.4m (up 12% from FY 2023). Net loss: UK£3.29m (loss narrowed 46% from FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.すべての更新を表示Recent updatesBoard Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Chairman Rakesh Sharma was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.お知らせ • May 14Kromek Group plc Provides Earnings Guidance for the 12-Month Period Ended 30 April 2026Kromek Group plc provided earnings guidance for the 12-month period ended 30 April 2026. For the period, the company estimates to be revenues of £27.2 million in line with market expectations.お知らせ • Dec 16Kromek Group plc to Report First Half, 2026 Results on Jan 20, 2026Kromek Group plc announced that they will report first half, 2026 results on Jan 20, 2026お知らせ • Oct 28Kromek Group plc Provides earnings Guidance for the First Half of 2026Kromek Group plc provided earnings guidance for the first half of 2026. For the first half, the group expects to report revenue of at least £14.5m (H1 2025: £3.7m). This includes revenue generated under the Group's enablement agreement with Siemens Healthineers, as announced on 30 January 2025, of at least £8.2m (H1 2024: £nil). Accordingly, on an underlying basis, the Group expects to report revenue of at least £6.3m (H1 2025: £3.7m), representing growth of 70% over the first half of 2025. This was driven by strong growth in the CBRN Detection division as well as an increase in underlying revenue in the Advanced Imaging division.お知らせ • Oct 03+ 1 more updateKromek Group plc, Annual General Meeting, Oct 27, 2025Kromek Group plc, Annual General Meeting, Oct 27, 2025. Location: kromek biosecurity boardroom, explorer 1 building, north east technology park netpark, thomas wright way, county durham ts21 3ff, sedgefield United Kingdomお知らせ • Sep 17Kromek Group plc Provides Earnings Guidance for the Fiscal Year 2026Kromek Group plc provided earnings guidance for the fiscal year 2026. For the year, the company expected to deliver further revenue growth and profitability, in line with market expectations.お知らせ • May 10+ 1 more updateKromek Group plc Announces CFO Changes, Effective 1 June 2025Kromek Group plc announced that Claire Burgess will be appointed as Chief Financial Officer ("CFO") of the Group, effective June 1, 2025. Claire Burgess has spent over 12 years in senior financial positions in businesses in the UK and US, primarily in the engineering and technology sectors. Most recently, Ms. Burgess was Financial Director of Advanced Electric Machines Group Ltd. ("AEM"), a designer and manufacturer of magnet-free electric powertrain technologies. Other experience includes being CFO of group companies JB Processing and TBGS Holdings and being responsible for establishing and building the US subsidiaries, including the acquisition of the Alabama White Marble Quarry. She is a qualified Fellow Chartered Accountant, having begun her career as an auditor at Ernst & Young before joining KPMG as a Corporate Finance Executive. Paul Farquhar is retiring and will therefore resign as CFO of the Group, effective June 1, 2025. Claire Burgess, aged 51, Current directorships and/or partnerships Former directorships and/or partnerships (within the last 5 years): Advanced Electric Machines Group Limited; Advanced Electric Machines Limited; Advanced Electric Machines Research Limited; Inn Collection (Bassenthwaite) Limited; Inn Collection Lakes (Ambleside) Limited; Inn Collection (Whitby) Limited; Inn Collection (Northallerton) Limited; Inn Collection (Helmsley) Limited; Inn Collection (Seaburn) Limited; Inn Collection Lakes (Coniston) Limited; Vindolanda Bidco Limited; Lindisfarne Inns Limited; Inn Collection Limited; Inn Collection AcquisitionCo Limited; Inn Collection Topco Limited; Inn Collection Midco Limited; Durham Vale Developments Limited; Vindolanda Midco 1 Limited; Marshall Inns Limited; Greensfield Moor Development Limited; Lindisfarne Inns (Bamburgh Castle) Limited; Inn Collection Bidco Limited; Vindolanda Topco Limited; Vindolanda Midco 2 Limited; Inn Collection Management Limited; and Inn Collection Lakes (Ambleside) Limited.お知らせ • Jan 30Kromek Group plc Provides Earnings Guidance for the Year 2025Kromek Group plc provided earnings guidance for the year 2025. For the period, the Group expects to become profitable, with profit significantly ahead of market expectations. The Group also expects to achieve further revenue growth beyond Fiscal Year 2025 while delivering sustainable profits.お知らせ • Nov 19Kromek Group plc, Annual General Meeting, Dec 13, 2024Kromek Group plc, Annual General Meeting, Dec 13, 2024. Location: kromek biosecurity boardroom, explorer 1 building, north east technology park netpark, thomas wright way, county durham, ts21 3ff, sedgefield United KingdomNew Risk • Nov 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Less than 1 year of cash runway based on current free cash flow (-UK£7.8m). Currently unprofitable and not forecast to become profitable next year (UK£3.4m net loss next year). Shareholders have been diluted in the past year (6.8% increase in shares outstanding). Market cap is less than US$100m (€50.6m market cap, or US$54.2m).Buy Or Sell Opportunity • Oct 29Now 24% overvaluedOver the last 90 days, the stock has fallen 1.5% to €0.066. The fair value is estimated to be €0.053, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 24% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 31% in a year. Earnings are forecast to decline by 3.2% in the next year.Reported Earnings • Oct 28Full year 2024 earnings released: UK£0.006 loss per share (vs UK£0.014 loss in FY 2023)Full year 2024 results: UK£0.006 loss per share (improved from UK£0.014 loss in FY 2023). Revenue: UK£19.4m (up 12% from FY 2023). Net loss: UK£3.29m (loss narrowed 46% from FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.New Risk • Aug 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended October 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported October 2023 fiscal period end). Currently unprofitable and not forecast to become profitable next year (UK£4.6m net loss next year). Share price has been volatile over the past 3 months (8.1% average weekly change). Shareholders have been diluted in the past year (5.3% increase in shares outstanding). Market cap is less than US$100m (€41.0m market cap, or US$45.2m).Board Change • Mar 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Chris Wilks was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.収支内訳Kromek Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史DB:4KM 収益、費用、利益 ( )GBP Millions日付収益収益G+A経費研究開発費31 Oct 25381317031 Jul 2532817030 Apr 2527417031 Jan 2521-115031 Oct 2416-613031 Jul 2418-513030 Apr 2419-313031 Jan 2419-413031 Oct 2318-414031 Jul 2317-514030 Apr 2317-615031 Jan 2316-715031 Oct 2214-814031 Jul 2213-614030 Apr 2212-513031 Jan 2211-512031 Oct 2110-512031 Jul 2110-511030 Apr 2110-511031 Jan 2111-1111031 Oct 2012-1711031 Jul 2013-1711030 Apr 2013-1711031 Jan 2015-911031 Oct 1916-110031 Jul 1915-110030 Apr 1915-19031 Jan 1913-19031 Oct 1811-29031 Jul 1811-19030 Apr 1812-19031 Jan 1811-29031 Oct 1710-310031 Jul 179-39030 Apr 179-39031 Jan 179-28031 Oct 169-18031 Jul 169-28030 Apr 168-29031 Jan 168-29031 Oct 158-39031 Jul 158-290質の高い収益: 4KMは 高品質の収益 を持っています。利益率の向上: 4KM過去に利益を上げました。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 4KM過去 5 年間で収益を上げており、収益は年間48.6%増加しています。成長の加速: 4KMは昨年収益を上げたため、収益成長率を 5 年間の平均と比較することは困難です。収益対業界: 4KM昨年収益を上げたため、昨年の収益成長をSemiconductor業界 ( -32.5% ) と比較することは困難です。株主資本利益率高いROE: 4KMの 自己資本利益率 ( 22% ) は 高い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YSemiconductors 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/28 18:08終値2026/06/26 00:00収益2025/10/31年間収益2025/04/30データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Kromek Group plc 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Michael MitchellCavendish
お知らせ • Dec 16Kromek Group plc to Report First Half, 2026 Results on Jan 20, 2026Kromek Group plc announced that they will report first half, 2026 results on Jan 20, 2026
Reported Earnings • Oct 28Full year 2024 earnings released: UK£0.006 loss per share (vs UK£0.014 loss in FY 2023)Full year 2024 results: UK£0.006 loss per share (improved from UK£0.014 loss in FY 2023). Revenue: UK£19.4m (up 12% from FY 2023). Net loss: UK£3.29m (loss narrowed 46% from FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
Board Change • May 20Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Non-Executive Chairman Rakesh Sharma was the last independent director to join the board, commencing their role in 2020. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
お知らせ • May 14Kromek Group plc Provides Earnings Guidance for the 12-Month Period Ended 30 April 2026Kromek Group plc provided earnings guidance for the 12-month period ended 30 April 2026. For the period, the company estimates to be revenues of £27.2 million in line with market expectations.
お知らせ • Dec 16Kromek Group plc to Report First Half, 2026 Results on Jan 20, 2026Kromek Group plc announced that they will report first half, 2026 results on Jan 20, 2026
お知らせ • Oct 28Kromek Group plc Provides earnings Guidance for the First Half of 2026Kromek Group plc provided earnings guidance for the first half of 2026. For the first half, the group expects to report revenue of at least £14.5m (H1 2025: £3.7m). This includes revenue generated under the Group's enablement agreement with Siemens Healthineers, as announced on 30 January 2025, of at least £8.2m (H1 2024: £nil). Accordingly, on an underlying basis, the Group expects to report revenue of at least £6.3m (H1 2025: £3.7m), representing growth of 70% over the first half of 2025. This was driven by strong growth in the CBRN Detection division as well as an increase in underlying revenue in the Advanced Imaging division.
お知らせ • Oct 03+ 1 more updateKromek Group plc, Annual General Meeting, Oct 27, 2025Kromek Group plc, Annual General Meeting, Oct 27, 2025. Location: kromek biosecurity boardroom, explorer 1 building, north east technology park netpark, thomas wright way, county durham ts21 3ff, sedgefield United Kingdom
お知らせ • Sep 17Kromek Group plc Provides Earnings Guidance for the Fiscal Year 2026Kromek Group plc provided earnings guidance for the fiscal year 2026. For the year, the company expected to deliver further revenue growth and profitability, in line with market expectations.
お知らせ • May 10+ 1 more updateKromek Group plc Announces CFO Changes, Effective 1 June 2025Kromek Group plc announced that Claire Burgess will be appointed as Chief Financial Officer ("CFO") of the Group, effective June 1, 2025. Claire Burgess has spent over 12 years in senior financial positions in businesses in the UK and US, primarily in the engineering and technology sectors. Most recently, Ms. Burgess was Financial Director of Advanced Electric Machines Group Ltd. ("AEM"), a designer and manufacturer of magnet-free electric powertrain technologies. Other experience includes being CFO of group companies JB Processing and TBGS Holdings and being responsible for establishing and building the US subsidiaries, including the acquisition of the Alabama White Marble Quarry. She is a qualified Fellow Chartered Accountant, having begun her career as an auditor at Ernst & Young before joining KPMG as a Corporate Finance Executive. Paul Farquhar is retiring and will therefore resign as CFO of the Group, effective June 1, 2025. Claire Burgess, aged 51, Current directorships and/or partnerships Former directorships and/or partnerships (within the last 5 years): Advanced Electric Machines Group Limited; Advanced Electric Machines Limited; Advanced Electric Machines Research Limited; Inn Collection (Bassenthwaite) Limited; Inn Collection Lakes (Ambleside) Limited; Inn Collection (Whitby) Limited; Inn Collection (Northallerton) Limited; Inn Collection (Helmsley) Limited; Inn Collection (Seaburn) Limited; Inn Collection Lakes (Coniston) Limited; Vindolanda Bidco Limited; Lindisfarne Inns Limited; Inn Collection Limited; Inn Collection AcquisitionCo Limited; Inn Collection Topco Limited; Inn Collection Midco Limited; Durham Vale Developments Limited; Vindolanda Midco 1 Limited; Marshall Inns Limited; Greensfield Moor Development Limited; Lindisfarne Inns (Bamburgh Castle) Limited; Inn Collection Bidco Limited; Vindolanda Topco Limited; Vindolanda Midco 2 Limited; Inn Collection Management Limited; and Inn Collection Lakes (Ambleside) Limited.
お知らせ • Jan 30Kromek Group plc Provides Earnings Guidance for the Year 2025Kromek Group plc provided earnings guidance for the year 2025. For the period, the Group expects to become profitable, with profit significantly ahead of market expectations. The Group also expects to achieve further revenue growth beyond Fiscal Year 2025 while delivering sustainable profits.
お知らせ • Nov 19Kromek Group plc, Annual General Meeting, Dec 13, 2024Kromek Group plc, Annual General Meeting, Dec 13, 2024. Location: kromek biosecurity boardroom, explorer 1 building, north east technology park netpark, thomas wright way, county durham, ts21 3ff, sedgefield United Kingdom
New Risk • Nov 09New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 11% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risk Share price has been highly volatile over the past 3 months (11% average weekly change). Minor Risks Less than 1 year of cash runway based on current free cash flow (-UK£7.8m). Currently unprofitable and not forecast to become profitable next year (UK£3.4m net loss next year). Shareholders have been diluted in the past year (6.8% increase in shares outstanding). Market cap is less than US$100m (€50.6m market cap, or US$54.2m).
Buy Or Sell Opportunity • Oct 29Now 24% overvaluedOver the last 90 days, the stock has fallen 1.5% to €0.066. The fair value is estimated to be €0.053, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 24% over the last 3 years. Earnings per share has grown by 17%. Revenue is forecast to grow by 31% in a year. Earnings are forecast to decline by 3.2% in the next year.
Reported Earnings • Oct 28Full year 2024 earnings released: UK£0.006 loss per share (vs UK£0.014 loss in FY 2023)Full year 2024 results: UK£0.006 loss per share (improved from UK£0.014 loss in FY 2023). Revenue: UK£19.4m (up 12% from FY 2023). Net loss: UK£3.29m (loss narrowed 46% from FY 2023). Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has fallen by 29% per year, which means it is significantly lagging earnings.
New Risk • Aug 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended October 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Minor Risks Latest financial reports are more than 6 months old (reported October 2023 fiscal period end). Currently unprofitable and not forecast to become profitable next year (UK£4.6m net loss next year). Share price has been volatile over the past 3 months (8.1% average weekly change). Shareholders have been diluted in the past year (5.3% increase in shares outstanding). Market cap is less than US$100m (€41.0m market cap, or US$45.2m).
Board Change • Mar 27Less than half of directors are independentNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 2 highly experienced directors. 3 independent directors (4 non-independent directors). Independent Non-Executive Director Chris Wilks was the last independent director to join the board, commencing their role in 2017. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.